All News

Using the DASH Rapid PCR System, providers can yield test results in under 1 minute of hands-on time.

A study found that sending a letter to providers about standards of care and glucagon preparations could increase glucagon prescription rates.

Researchers explored ideas of simplifying the vaccination process to yield higher rates of adult immunization, similar to that of the COVID-19 pandemic.

Researchers aimed to identify the barriers impeding HPV vaccine uptake since 2019 among US mid-adults aged 27 to 45.

Jennifer Goldman, PharmD, CDCES, BC-ADM, discusses how putting glucagon kits in public areas and long-term care facilities can help patients with diabetes.

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses the benefits of glucagon and why pharmacists should be able to prescribe it.

XG005 from Xgene Pharmaceutical is a novel, non-opioid chemical entity that targets anti-nociceptive and anti-neuropathic pain pathways.

Check out this list of our top 5 most read immunization stories from the year 2024.

Check out this list of our top 5 most read nonopioid pain management stories from the year 2024.

Check out this list of our top 5 most read diabetes stories from the year 2024.

Check out this list of our top 5 most read women’s health stories from the year 2024.

Check out this list of our top 5 most read infectious disease stories from the year 2024.

Check out this list of our top 5 most read pain management stories from the year 2024.

Check out this list of our top 5 most read cardiology stories from the year 2024.

Check out this list of our top 5 most read digestive health stories from the year 2024.

Check out this list of our top 5 most read Total Pharmacy stories from the year 2024.

Check out this list of our top 5 most read COVID-19 stories from the year 2024.

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, professor of pharmacy practice at Massachusetts College of Pharmacy and Health Sciences, discuses the benefits of glucagon.

Check out this list of our top 5 most read Drug Topics stories from the year 2024.

Provisions under the Inflation Reduction Act have ensured cost savings for patients prescribed drugs covered under Medicare Part B.

Senators Elizabeth Warren and Tina Smith have reintroduced the Pharmaceutical Supply Chain Defense and Enhancement Act originally established in 2020.

A study found that patients with medication-overuse headache and neck pain experience earlier onset of primary headache and decreased quality of life.

Researchers reviewed Medicaid policies to understand vaccine coverage and reimbursement rates among physicians and pharmacists.

A conversation with Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, professor of pharmacy practice at Massachusetts College of Pharmacy and Health Sciences.

Researchers explored the impacts of natural bioactive compounds for the treatment of acute pancreatitis.

Zepbound from Eli Lilly is the first and only prescription medicine approved by the FDA for adults with obstructive sleep apnea and obesity.

Authors concluded that that the benefit of the vaccine in preventing long COVID is due mainly to the fact it mitigates the risk of infection.

Although the drug fell short of its 25% expected weight loss, results are still promising for people with overweight or obesity.